Exploring Novel Frontiers in Cancer Therapy.
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
18 Jun 2024
18 Jun 2024
Historique:
received:
11
06
2024
accepted:
14
06
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
Cancer progression and initiation are sustained by a series of alterations in molecular pathways because of genetic errors, external stimuli and other factors, which lead to an abnormal cellular function that can be translated into uncontrolled cell growth and metastasis [...].
Identifiants
pubmed: 38927551
pii: biomedicines12061345
doi: 10.3390/biomedicines12061345
pii:
doi:
Types de publication
Editorial
Langues
eng